Sinaiko v. Superior Court

19 Cal. Rptr. 3d 371, 122 Cal. App. 4th 1133, 2004 Cal. Daily Op. Serv. 8983, 2004 Daily Journal DAR 12230, 2004 Cal. App. LEXIS 1637
CourtCalifornia Court of Appeal
DecidedSeptember 30, 2004
DocketC045502
StatusPublished
Cited by11 cases

This text of 19 Cal. Rptr. 3d 371 (Sinaiko v. Superior Court) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sinaiko v. Superior Court, 19 Cal. Rptr. 3d 371, 122 Cal. App. 4th 1133, 2004 Cal. Daily Op. Serv. 8983, 2004 Daily Journal DAR 12230, 2004 Cal. App. LEXIS 1637 (Cal. Ct. App. 2004).

Opinion

Opinion

RAYE, J.

In its next life, this case may raise fascinating issues involving the standard of care when a physician employs alternative therapies for children suffering from attention deficit and hyperactivity disorder (ADHD) or adults suffering from a wide assortment of hard-to-diagnose symptoms. But in the writ proceedings now before us, we are presented with a more basic deprivation of due process—the wholesale disqualification of petitioner’s experts.

The trial court acknowledged the “glaring error” but refused to remand the case to real party in interest Medical Board of California (Board) to either *1137 consider the testimony offered by the expert witnesses of petitioner Robert Sinaiko, M.D., or to “bridge the analytic gap” between its finding that the witnesses were credible and its conclusion that they were not qualified. (Topanga Assn. for a Scenic Community v. County of Los Angeles (1974) 11 Cal.3d 506, 515 [113 Cal.Rptr. 836, 522 P.2d 12] (Topanga).) Moreover, the erroneous notion that the Kelly-Frye standards of admissibility of scientific evidence established the standard of care infiltrated the administrative proceedings. (People v. Kelly (1976) 17 Cal.3d 24 [130 Cal.Rptr. 144, 549 P.2d 1240] (Kelly); Frye v. United States (D.C. Cir. 1923) 293 F. 1013 (Frye), superseded by rule as noted in Daubert v. Merrell Dow (1993) 509 U.S. 579 [125 L.Ed.2d 469, 113 S.Ct. 2786].) Because the Board’s disqualification of petitioner’s experts rendered his hearing fundamentally unfair, particularly when the standard of care was obfuscated by Kelly-Frye standards of admissibility, we must remand the case to the Board and postpone consideration of the many issues raised by the parties and amici curiae.

ALLEGATIONS, PROCEEDINGS, AND FINDINGS

Petitioner is Board certified in internal medicine and allergy and clinical immunology. On November 1, 1996, the Board filed an accusation alleging that petitioner’s treatment of nine-year-old L.T.S. “constitutes an extreme departure from the prevailing standard of practice among the community of California licensed practitioners. [][] ... [][].. . Overall, [petitioner’s] care and treatment of minor patient L.T.S. was well outside the prevailing standard of practice of medicine in that he failed to take an adequate history and physical examination; to develop and follow a rational and methodical plan, especially in such a non-emergent case; to give or even allow an adequate trial of accepted treatments (i.e.[J Ritalin) before moving on to treatments which are not only controversial but have serious and unknown risks associated with them and by failing to provide some sort of support for the original diagnosis.”

On February 27, 1997, the Board filed an amended and supplemental accusation, wherein it alleged that petitioner negligently cared for three additional patients between 1986 and 1993. The Board asserted that petitioner treated a 32-year-old male, J.H.; a 30-year-old female, S.L.; and a 24-year-old male, R.S., in a grossly negligent (Bus. & Prof. Code, § 2234, subd. (b)) and/or repeatedly negligent (Bus. & Prof. Code, § 2234, subd. (c)) and/or incompetent (Bus. & Prof. Code, § 2234, subd. (d)) manner. All three patients displayed a myriad of unusual symptoms. The allegations all involved petitioner’s consistent use of a handful of antifungal drugs and medical treatments, including dietary restrictions, to treat allergies and other chronic immunologic disorders. Petitioner prescribed various drugs, according to the amended accusation, that had not been approved by the Federal Drug *1138 Administration (FDA) in the form ordered. Additionally, the Board alleged that in failing to comply with FDA Institutional Review Board requirements and to provide proper informed consent, petitioner was engaged in improper human experimentation on his patients.

Medical experts offered divergent opinions about the standard of care during the 26-day administrative hearing. It is a fair reading of the record to say that there was some confusion over the applicability of the Kelly-Frye test governing the use of new scientific techniques, including its language regarding general or widespread acceptance. Throughout the hearing, the Attorney General attempted to portray petitioner as a “quack” using “unproven” and “dubious” treatments that were not “generally-accepted” by the medical community. He suggested that any practice method that is not generally accepted falls outside the standard of practice.

For example, during cross-examination of one of the Board’s experts, petitioner’s lawyer attempted to use a grid to distill precisely in what way the expert believed petitioner’s care and treatment of his patients fell below the standard of care. The Attorney General objected, characterizing the issue as “the classic Kelly[-]Frye situation.” He argued, “This is really a back-door, end-around to Kelly[-]Frye for purposes of trying to get to the gist of this case, which is EPD [enzyme potentiated desensitization]. The testimony has been clear from Dr. Terr. His testimony has been that it is his opinion that EPD and betaglucuronidase and the Multiple Chemical Sensitivity diagnosis and the Clinical Ecology movement within medicine has not gained the level of acceptance from the general mainstream community to allow it to come into evidence for the purposes of satisfying an evidentiary relevancy objection.” Moreover, throughout the examination and cross-examination of the witnesses, the Attorney General asked whether the particular treatment or drug regimen was “generally accepted” or had “gained widespread acceptance.”

Based on 23 findings of cause for discipline sustaining the essential allegations in the accusation, the administrative law judge (ALJ) recommended that the Board revoke petitioner’s license. Central to the dispositive issue now before us, the ALJ found: “The experts who testified on behalf of the [petitioner] concerning such medical diagnoses as Multiple Chemical Sensitivity, Environmental Illness, Chronic Fatigue Syndrome and Candida Hypersensitivity and that Candida Hypersensitivity causes symptoms and diseases such as Attention Deficit Hyperactivity Disorder, Autism or other behavioral disorders were of questionable credibility in that their testimony was not based on generally accepted scientific and medical principles as required by such cases as Daubert v. Merrell Dow Pharmaceuticals, Inc. (1993) 509 U.S. 579 [125 L.Ed.2d 469, 113 S.Ct. 2786].” Petitioner does not *1139 otherwise challenge the sufficiency of the evidence to support the findings of the ALT, the Board, or the trial court.

The Board adopted the ALJ’s proposed decision and revoked petitioner’s license. In August 1998 petitioner requested reconsideration.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Miller v. Dept. of Real Estate
California Court of Appeal, 2022
People v. Smith CA2/8
California Court of Appeal, 2020
Greene v. California Coastal Commission
California Court of Appeal, 2019
Hall v. Superior Court of San Diego County
3 Cal. App. 5th 792 (California Court of Appeal, 2016)
Tuckwell v. State Personnel Board CA1/1
California Court of Appeal, 2015
Burnell v. Marin Humane Society CA1/1
California Court of Appeal, 2014
Ventimiglia v. Board of Behavioral Sciences
168 Cal. App. 4th 296 (California Court of Appeal, 2008)
Manufactured Home Communities, Inc. v. County of San Luis Obispo
167 Cal. App. 4th 705 (California Court of Appeal, 2008)
Voices of Wetlands v. STATE WATER RES. BD.
69 Cal. Rptr. 3d 487 (California Court of Appeal, 2008)
D.H. Williams Construction, Inc. v. Clovis Unified School District
53 Cal. Rptr. 3d 345 (California Court of Appeal, 2007)

Cite This Page — Counsel Stack

Bluebook (online)
19 Cal. Rptr. 3d 371, 122 Cal. App. 4th 1133, 2004 Cal. Daily Op. Serv. 8983, 2004 Daily Journal DAR 12230, 2004 Cal. App. LEXIS 1637, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sinaiko-v-superior-court-calctapp-2004.